Transdermal fentanyl in chronic nonmalignant pain
Chronic non malignant pain is always a therapeutic challenge of great significance because a inappropriate and insufficient treatment is able to reduce the life’s quality of the patients. Many therapeutic strategies were used to solve these issues, no one exhaustive. In the treatment of cancer pain,...
Main Authors: | Vittorio Iorno, Vincenzo Moschini, Elena Rota |
---|---|
Format: | Article |
Language: | English |
Published: |
Publiediting
2006-09-01
|
Series: | Pathos |
Subjects: | |
Online Access: | http://www.pathos-journal.com/doc/2006_3_RassegnaFentanyl_Iorno.pdf |
Similar Items
-
Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review
by: Ahn JS, et al.
Published: (2017-08-01) -
Treatment of Severe Cancer Pain by Transdermal Fentanyl
by: Dženita Ljuca, et al.
Published: (2010-05-01) -
Comparison between Transdermal Buprenorphine and Transdermal Fentanyl for Postoperative Pain Relief after Major Abdominal Surgeries
by: Zia Arshad, et al.
Published: (2015-12-01) -
Three-cycle fentanyl patch system contributes to stable control of plasma fentanyl concentration in gynecologic cancer pain patients
by: Chiharu Kanamori, et al.
Published: (2011-03-01) -
Fentanyl transdermal patch: The silent new killer?
by: Martina Zanon, et al.
Published: (2020-12-01)